IMPROVING
CANCER PAIN RELIEF
IN THE WORLD
REPORT FOR 2001
![]() |
World Health Organization Collaborating Center for Policy and Communications in Cancer Care |
Sponsored by
The Pain & Policy Studies Group
University of Wisconsin Comprehensive Cancer Center
The Medical School
Madison, Wisconsin USA
www.medsch.wisc.edu/painpolicy
September 2002
Table of Contents
Executive Summary
The Center and its WHO Terms of Reference
Staff Members Acknowledgements
This report summarizes the work of the World Health Organization Collaborating Center (the Center) for Policy and Communications in Cancer Care. The Center is designated by the Pan American Health Organization (PAHO) and sponsored by the Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center, Medical School in Madison, Wisconsin, U.S.A.
In 2001, the Center collaborated extensively with WHO Headquarters programs in Essential Drugs and Medicines, Cancer, HIV/AIDS, and Long-Term Care, and WHO Regional Offices in the Americas, Europe, and South-East Asia.
In July 2001, the Center met with the WHO Regional Office for Europe (EURO) and the Open Society Institute to plan a regional workshop on opioid availability for six countries in Eastern Europe.
In August 2001, the Center met with PAHO to review follow-up work needed subsequent to the December 2000 PAHO/Center 6-country workshop on opioid availability for palliative care held in Quito, Ecuador.
In December 2001, the Center participated in the “WHO Research Partners Meeting” to increase collaboration between WHO and external partners on non-communicable disease research priorities.
In 2001, the Center continued its cooperation with the International Narcotics Control Board (INCB) regarding global opioid availability. The Center uses INCB statistics on consumption of opioids to monitor global and national trends in availability and medical use of opioid analgesics.
In 2001, the Center and a key collaborator in India published an article in Lancet that reported outcomes from a WHO Demonstration Project in Calicut, India (designated by the Center) to make opioids available for the relief of pain in terminally ill patients living at home, without diversion and abuse. In 2001, the Center and the Demonstration Project sponsored additional workshops on morphine availability for palliative care and simplification of state regulations in India.
The Center accomplishes its policy work through a program of research, development, demonstration, monitoring, evaluation, and communications. The Center develops methods, procedures and models that can be used to identify barriers to opioid availability, diagnose regulatory problems, make changes in national and state policy, and monitor outcomes.
The Center accomplishes its communications work through the publication of Cancer Pain Release, a quarterly WHO newsletter that provides health professionals, policy makers, and regulators throughout the world with updates on issues and developments in the field. Cancer Pain Release is disseminated to approximately 50,000 health-care professionals in 173 countries and is inserted in national and international pain and palliative medicine journals.
The Center participates in international and national conferences and strategy
meetings for health professionals and government officials, and provides technical
assistance to government and non-government organizations. The Center maintains
policy and communications websites and promotes better understanding of the
principle of balance that should guide national narcotics control policy to
ensure availability of opioid pain medications under adequate control to prevent
diversion.
The Center and its WHO Terms of Reference
Name of Center: The World Health Organization
Collaborating Center for Policy and Communications in Cancer Care
Address: Pain
& Policy Studies Group
University of Wisconsin Comprehensive Cancer Center
406 Science Drive, Suite 202
Madison, Wisconsin, 53711-1068, USA
Telephone: 1 608 263 7662
Facsimile: 1 608 263 0259
Email: joranson@wisc.edu
Websites: http://www.medsch.wisc.edu/painpolicy
http://www.WHOcancerpain.wisc.edu
Director: David E. Joranson, MSSW, Senior Scientist, Pain & Policy Studies Group
Terms of Reference for the Collaborating Center: *
1. To develop methods to identify impediments to the availability of opioid analgesics; compare national approaches to opioid analgesic regulation; develop procedures to monitor the medical use and diversion of opioids before and after national cancer pain and palliative care policies are implemented.
2. Develop WHO Demonstration Projects to make opioids available for cancer pain relief while minimizing diversion.
3. To monitor development of national cancer pain relief and palliative care programs according to WHO’s three measures of national policy, opioid availability and educational programs.
4. To maintain a communication network for the WHO Cancer Pain Relief and Palliative Care Program, including publication of a WHO/PAHO, Global Cancer Care newsletter to be distributed throughout the world, and a computer-based telecommunication system giving professionals the opportunity to access and share information.
5. Establish a comprehensive database of resources available to educate cancer patients about pain control and palliative care and configure the information so that is can be easily retrievable.
* These terms of reference were revised in 2002, and will be reflected in the 2002 report.
Madison, Wisconsin, USA
September 17, 2002David E. Joranson
Director
David E. Joranson, MSSW, Director
Sophie M. Colleau, PhD, Editor, Cancer Pain Release
Aaron M. Gilson, PhD, Assistant Director & Researcher for Policy Studies
Janet F. Kline, MLS, Research Program Administrator
Karen M. Ryan, MA, Senior Policy Analyst
Martha A. Maurer, BS, Policy Analyst
Jody P. Jorenby, BA, Policy Specialist & Communications Coordinator
Linda L. Gorman, Program Assistant
The Center wishes to acknowledge the cooperation of the following individuals:
Professor M.R. Rajagopal, Director of the Pain and Palliative Care Society and
WHO Demonstration Project, Calicut, India; Mr. Kailash Sethi, former Narcotics
Commissioner of India, New Delhi, India; Mr. Romesh Bhattacharji, former Narcotics
Commissioner of India, Gwalior, India; the WHO Regional Office for Europe, Copenhagen,
Denmark; and the International Narcotics Control Board Secretariat, Vienna,
Austria.